Cargando…

Toll-Like Receptors in Atherosclerosis

Atherosclerosis, the leading cause of cardiovascular disease (CVD), is driven by inflammation. Increasing evidence suggests that toll-like receptors (TLRs) are key orchestrators of the atherosclerotic disease process. Interestingly, a distinct picture is being revealed for individual receptors in at...

Descripción completa

Detalles Bibliográficos
Autores principales: Falck-Hansen, Mika, Kassiteridi, Christina, Monaco, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742229/
https://www.ncbi.nlm.nih.gov/pubmed/23880853
http://dx.doi.org/10.3390/ijms140714008
_version_ 1782280338815320064
author Falck-Hansen, Mika
Kassiteridi, Christina
Monaco, Claudia
author_facet Falck-Hansen, Mika
Kassiteridi, Christina
Monaco, Claudia
author_sort Falck-Hansen, Mika
collection PubMed
description Atherosclerosis, the leading cause of cardiovascular disease (CVD), is driven by inflammation. Increasing evidence suggests that toll-like receptors (TLRs) are key orchestrators of the atherosclerotic disease process. Interestingly, a distinct picture is being revealed for individual receptors in atherosclerosis. TLRs exhibit a complex nature enabling the detection of multiple motifs named danger-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs). Activation of these receptors triggers an intracellular signalling cascade mediated through MyD88 or TRIF, leading to the production of pro- and anti-inflammatory cytokines. In this review we explore key novel findings pertaining to TLR signalling in atherosclerosis, including recently described endosomal TLRs and future directions in TLR research.
format Online
Article
Text
id pubmed-3742229
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-37422292013-08-13 Toll-Like Receptors in Atherosclerosis Falck-Hansen, Mika Kassiteridi, Christina Monaco, Claudia Int J Mol Sci Review Atherosclerosis, the leading cause of cardiovascular disease (CVD), is driven by inflammation. Increasing evidence suggests that toll-like receptors (TLRs) are key orchestrators of the atherosclerotic disease process. Interestingly, a distinct picture is being revealed for individual receptors in atherosclerosis. TLRs exhibit a complex nature enabling the detection of multiple motifs named danger-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs). Activation of these receptors triggers an intracellular signalling cascade mediated through MyD88 or TRIF, leading to the production of pro- and anti-inflammatory cytokines. In this review we explore key novel findings pertaining to TLR signalling in atherosclerosis, including recently described endosomal TLRs and future directions in TLR research. Molecular Diversity Preservation International (MDPI) 2013-07-04 /pmc/articles/PMC3742229/ /pubmed/23880853 http://dx.doi.org/10.3390/ijms140714008 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Falck-Hansen, Mika
Kassiteridi, Christina
Monaco, Claudia
Toll-Like Receptors in Atherosclerosis
title Toll-Like Receptors in Atherosclerosis
title_full Toll-Like Receptors in Atherosclerosis
title_fullStr Toll-Like Receptors in Atherosclerosis
title_full_unstemmed Toll-Like Receptors in Atherosclerosis
title_short Toll-Like Receptors in Atherosclerosis
title_sort toll-like receptors in atherosclerosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742229/
https://www.ncbi.nlm.nih.gov/pubmed/23880853
http://dx.doi.org/10.3390/ijms140714008
work_keys_str_mv AT falckhansenmika tolllikereceptorsinatherosclerosis
AT kassiteridichristina tolllikereceptorsinatherosclerosis
AT monacoclaudia tolllikereceptorsinatherosclerosis